Navigation Links
Tyber Medical Closes Private Placement Funding Round
Date:11/25/2013

MORRISTOWN, N.J., Nov. 25, 2013 /PRNewswire/ -- Tyber Medical, LLC, a privately held medical device company focused on developing innovative spine and orthopaedic devices for private label opportunities and first to market with titanium plasma spray coated direct lateral implants for the spine, announces the closing of a successful initial funding round.

(Photo: http://photos.prnewswire.com/prnh/20131125/NY23376LOGO )

Tyber Medical, LLC, a market leader in titanium plasma spray coated interbody fusion devices, today announced it closed a private equity funding round for an undisclosed amount. The company will use the capital to acquire resources necessary to accelerate the market penetration of the TyPEEK interbody product portfolio, and develop additional products for the spine and orthopedic markets.

TyPEEK, proprietary titanium plasma sprayed interbody fusion devices, are specifically designed for situations where PEEK alone may not provide the best setting for fusion. TyPEEK is designed to offer the benefits of bone - titanium osseointegration along with the modulus and post op imaging characteristics of PEEK.

"This initial round of fundraising allows us to accelerate our domestic and international sales strategy, with continued development of future trauma and extremity products to complement our customers' existing product lines," commented Jeff Tyber, CEO and President of Tyber Medical.

About Tyber Medical:

Tyber Medical, LLC, Morristown, New Jersey, a private labeler Original Equipment Manufacturer (OEM), is creating new pathways to regulatory approved implants and instruments for orthopedic companies, large distributors, and hospital organizations. Tyber Medical designs and develops full class II orthopedic systems; verifies and validates those systems using a QSR and ISO 13485 certified quality system; and pursues and maintains both US (FDA 510k) and OUS (CE Mark) regulatory approvals. Current products include spinal interbody spacers featuring both standard sterile and non-sterile PEEK and TyPEEK™, a proprietary titanium plasma sprayed PEEK. For more information, please visit www.tybermedical.com.

Tyber Medical Interbody systems are made with PEEK-OPTIMA® from Invibio® Biomaterial Solutions.

Contact:
Steve Zeiger
89 Headquarters Plaza North, #1464
Morristown, New Jersey 07960
(866) 761-0933
szeiger@tybermed.com


'/>"/>
SOURCE Tyber Medical, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Tyber Medical Elects Arthur Alfaro As Board Member
2. Tyber Medical Adds Surgeon Advisors
3. Lung Cancer Alliance Congratulates 75 Medical Centers For Moving Swiftly And Responsibly On Lung Cancer Screening
4. Medical Device Developers - Network at BIOMEDevice Boston Next Week
5. Winner Medicals Special Committee Appoints Independent Financial Advisor and Retains Legal Counsel
6. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
7. CareFusion to Sell Neurodiagnostic Business to Natus Medical for $58 Million
8. ulrich medical USA™ Releases New Expandable Spinal Implant for US Market
9. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
10. Essential Medical Dismisses Patent Case against Masimo and Cercacor
11. Aethlon Medical Note: An Unprecedented Data Point, The Single-Treatment Capture of Hepatitis C Virus (HCV) by the Aethlon Hemopurifier®
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... , April 20, 2017 Research and ... Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, ... report to their offering. ... The global pharmacogenomics market was valued at US$ 7,167.6 Mn ... by 2024, expanding at a CAGR of 5.6% from 2016 ...
(Date:4/20/2017)... LUND, Sweden , April 20, 2017 /PRNewswire/ ... OTCQX: NEVPF) ("NeuroVive") today announced positive preclinical ... company,s preclinical compound for non-alcoholic steatohepatitis (NASH), ... NV556 has previously ... STAM™ NASH model. Today, NeuroVive,s scientists present ...
(Date:4/19/2017)... April 19, 2017 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) ... & Co. Healthcare Investor Conference 2017 at the Sheraton Hotel in ... , Chief Executive Officer of the Company is scheduled to present ... Richard Bear and the Chairman of the Board, Tony ... ...
Breaking Medicine Technology:
(Date:4/28/2017)... ... April 28, 2017 , ... ... could substantially improve drug safety and minimize the cost of development. In this ... channel inhibition using cell lines and for cardiac toxicity using induced pluripotent stem ...
(Date:4/28/2017)... , ... April 28, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House ... name the Creator responds to and which He does not. Yisrayl says with so ... one is the true name, but he says with a little Scripture, backed with a ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... their work assisting the Brooke Grove Foundation implement a Microsoft Dynamics GP solution ... Solutions, a leading ERP expert that specializes in long-term care, Brooke Grove now ...
(Date:4/28/2017)... ... April 28, 2017 , ... Rob Lowe is a popular actor that has ... presence to an educational purpose as the host of the “Informed” series. The program ... a recent episode, the series focuses on thyroid cancer. , Although thyroid cancer is ...
(Date:4/27/2017)... and DENVER (PRWEB) , ... April 27, 2017 ... ... Health, the nation’s leading respiratory hospital, based in Denver, Colorado, announced an agreement ... is enabled by the continuing support of the Jane and Leonard Korman Family ...
Breaking Medicine News(10 mins):